跳至主要内容
临床试验/IRCT20191105045340N2
IRCT20191105045340N2尚未招募3 期

The effect of bromelain supplementation on disease activity, quality of life and fecal calprotectin level in patients with inflammatory bowel disease

Iran University of Medical Sciences0 个研究点目标入组 84 人开始时间: 待定最近更新:
适应症

试验速览

阶段
3 期
状态
尚未招募
入组人数
84

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 years 至 70 years(—)
性别
All

入选标准

  • Diagnosis of inflammatory bowel disease based on the diagnosis of a gastroenterologist
  • Having mild to moderate disease activity in ulcerative colitis and mild to moderate disease activity in Crohn's
  • Minimum age of 18 years and maximum of 70 years
  • People express their satisfaction to participate in the study

排除标准

  • Alcohol consumption in the last 1 month
  • Pregnancy and breastfeeding
  • The consumption of antioxidant, vitamin and mineral supplements in the last 2 months
  • The consumption of antidepressants
  • The consumption of anticoagulant drugs
  • The consumption of drugs against tumor necrosis factor alpha
  • The consumption of steroidal and non-steroidal anti-inflammatory agents, antibiotics, fiber, probiotic during the two weeks before the intervention.
  • Having kidney diseases
  • Having liver diseases
  • Having thyroid diseases
  • Having diabetes
  • Having hypotension and hypertension
  • Having cardiovascular disease
  • Having Biliary diseases
  • Having endocrine diseases
  • Having mental disorders or neurological diseases
  • Having Cushing's syndrome
  • Having polycystic ovary syndrome
  • Having anemia
  • Having hemophilia
  • Having leukopenia
  • Having thrombocytopenia
  • Having asthma
  • Having cancer
  • Having anorexia and bulimia nervosa
  • Having autoimmune diseases
  • Having gastroesophageal reflux disease
  • Other gastrointestinal diseases and extensive gastrointestinal surgeries that affect the condition of the disease
  • Having other chronic inflammatory and autoimmune diseases according to the physician diagnosis

研究者

相似试验